Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.


CSE:SONA - Post by User

Bullboard Posts
Comment by stingray88on Oct 18, 2020 3:27pm
181 Views
Post# 31736396

RE:RE:To confirm

RE:RE:To confirm
Moemoney42 wrote:
Moemoney42 wrote: my earlier suspicions about finances, also supported by a few on this board (ie: Stingray) my research of the recent Sedar IFS only to find something that pretty much confirms my opinion of a PP coming soon.. the FS shows no cash on hand and only a balance of "restricted cash" available from the gov't grant... this could explain the recent trading pattern..? quote from the latest FS:

Sona Nanotech Inc. Unaudited Interim Statements of Financial Position As at July 31, 2020 and October 31, 2019 1 Expressed in Canadian dollars July 31, 2020 October 31, 2019 $ $ Assets Current assets Cash - 580,656 Restricted cash (note 4) 582,969 - Amounts receivable and other (note 5) 63,137 32,886 Inventory – raw materials 835,285 - Marketable securities 8,000 4,500 1,489,391 618,042 Property and equipment (note 6) 193,345 241,169 Total assets 1,682,736 859,211 Liabilities Current liabilities Accounts payable and accrued liabilities (note 7) 2,533,967 718,176 Deferred government grant (note 4) 347,614 - Current portion of long-term debt (note 8) 978,332 - Convertible notes and accrued interest (note 9) - 496,659 3,859,913 1,214,835 Long-term debt (note 8) - 666,819 Total liabilities 3,859,913 1,881,654 Equity Shareholders’ deficiency (2,177,177) (1,022,443) Total liabilities and equity 1,682,736 859,211

During the period ended July 31, 2020, eligible expense recoveries of $3,160,762 were incurred. Of that amount, $2,925,407 was paid in cash and $235,355 is included in accounts payable as of July 31, 2020. The balance of restricted cash is $582,969.
 

Then as I read further in the FS quote:
During the period ended July 31, 2020, the Company granted 2,100,000 stock options under the Company’s stock option plan. 1,740,000 of the stock options were issued to directors and officers of Sona. 540,000 of the options issued to related parties are exercisable into one common share at a price of $0.60 per share, vest at the rate of 25% every six months and will expire on March 17, 2025. 900,000 of the options issued to related parties are exercisable into one common share at a price of $7.47 per share, vest at the rate of 25% every six months and will expire on July 7, 2025.


Well done Moe! Our suspicions had foundation after all. We keep hearing about DOING DD , well this definitely falls under that category. Mentioned my spider senses were tingling 2 weeks ago at the odd trading patterns but the longs wouldn't hear of it. 
The troubling fact about the pumping board is they think we are bashers. I know I own shares as do you. We probably hold more than them. It's important to keep it honest and real. 
Bullboard Posts